HIMS logo

Hims & Hers Health (HIMS)

Profile

Full Name

Hims & Hers Health, Inc.

Ticker Symbol

HIMS

Exchange

NYSE

Country

United States

IPO

September 13, 2019

Indexes

Not included

Employees

1637

Key Details

Price

$27.23(+1.57%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.48B(+69.32% YoY)

Annual EPS

$0.53(+581.82% YoY)

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 10, 25 Truist Securities
Hold
Mar 18, 25 B of A Securities
Underperform
Mar 6, 25 Citigroup
Sell
Mar 6, 25 B of A Securities
Underperform
Feb 26, 25 Truist Securities
Hold
Feb 25, 25 Piper Sandler
Neutral
Feb 25, 25 Needham
Buy
Feb 25, 25 Leerink Partners
Market Perform
Feb 25, 25 Citigroup
Sell
Feb 20, 25 B of A Securities
Underperform

Institutional Ownership

  • What is the ticker symbol for Hims & Hers Health?
  • Does Hims & Hers Health pay dividends?
  • What sector is Hims & Hers Health in?
  • What industry is Hims & Hers Health in?
  • What country is Hims & Hers Health based in?
  • When did Hims & Hers Health go public?
  • Is Hims & Hers Health in the S&P 500?
  • Is Hims & Hers Health in the NASDAQ 100?
  • Is Hims & Hers Health in the Dow Jones?
  • When was Hims & Hers Health's last earnings report?
  • When does Hims & Hers Health report earnings?
  • Should I buy Hims & Hers Health stock now?

What is the ticker symbol for Hims & Hers Health?

The ticker symbol for Hims & Hers Health is NYSE:HIMS

Does Hims & Hers Health pay dividends?

No, Hims & Hers Health does not pay dividends

What sector is Hims & Hers Health in?

Hims & Hers Health is in the Consumer Defensive sector

What industry is Hims & Hers Health in?

Hims & Hers Health is in the Household & Personal Products industry

What country is Hims & Hers Health based in?

Hims & Hers Health is headquartered in United States

When did Hims & Hers Health go public?

Hims & Hers Health's initial public offering (IPO) was on September 13, 2019

Is Hims & Hers Health in the S&P 500?

No, Hims & Hers Health is not included in the S&P 500 index

Is Hims & Hers Health in the NASDAQ 100?

No, Hims & Hers Health is not included in the NASDAQ 100 index

Is Hims & Hers Health in the Dow Jones?

No, Hims & Hers Health is not included in the Dow Jones index

When was Hims & Hers Health's last earnings report?

Hims & Hers Health's most recent earnings report was on Feb 24, 2025

When does Hims & Hers Health report earnings?

The next expected earnings date for Hims & Hers Health is May 6, 2025

Should I buy Hims & Hers Health stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page